Lv75
3900 积分 2022-12-19 加入
Dual Targeting of B Cell Compartments Using Belatacept and Daratumumab in Highly Sensitized Kidney Transplant Candidates: A Mechanistic Proof-of-Concept desensitization Trial
2天前
求助中
Reversing Transplant Ineligibility With Teclistamab in Ultra–High-Risk Relapsed/Refractory Multiple Myeloma With Extramedullary Disease
9天前
已完结
Preferred standard‐of‐care carfilzomib dosing in multiple myeloma: An international survey of haematologists/oncologists
15天前
已完结
Antibiotic-associated dysbiosis and bispecific antibody outcomes in multiple myeloma
23天前
已完结
Therapy-induced rapid drug resistance driven by genome chaos and polyploid giant cancer cells
27天前
已关闭
Progressive Multifocal Leukoencephalopathy (PML) in 2 Patients Treated With Elranatamab
1个月前
已关闭
Real-World Outcomes of Newly Diagnosed Multiple Myeloma Patients Treated With Front-Line Daratumumab Lenalidomide and Dexamethasone
1个月前
已完结
Biting the Tail of CAR-T for Relapsed Multiple Myeloma
1个月前
已完结
Efficacy and Safety Comparisons of Four Approved Chimeric Antigen Receptor T‐Cell Therapies in Multiple Myeloma
1个月前
已完结
皖公网安备34019202002308
